Physician profile
Stephanie Simpson
NPI 1437828704
$1,397.81
in general payments reported to CMS, 2019-2025
11 companies · $719 in 2025
The $719 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $190 · 2024: $488 · 2025: $719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155 · Education: $52.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.33 |
| Education | $52.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $380.21 | 2024-2025 | |
| Amgen INC. | $193.22 | 2022-2025 | Krystexxa |
| Ardelyx, INC. | $170.29 | 2024-2025 | Xphozah 30 Mg, Ibsrela |
| Calliditas Therapeutics US INC. | $161.85 | 2024-2025 | Tarpeyo |
| Vifor Pharma, INC. | $142.51 | 2024-2025 | Veltassa |
| Astrazeneca Pharmaceuticals Lp | $80.80 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.18 | 2024 | Jardiance |
| Medtronic, INC. | $63.52 | 2025 | Ellipsys Vascular Access System |
| Opko Pharmaceuticals, LLC | $52.04 | 2025 | Rayaldee |
| Otsuka America Pharmaceutical, INC. | $43.14 | 2024-2025 | Jynarque |
| Travere Therapeutics, INC. | $31.05 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.